BioCryst Pharmaceuticals Inc (BCRX)
4.44
-0.06
(-1.33%)
USD |
NASDAQ |
Apr 19, 16:00
4.43
-0.01
(-0.23%)
After-Hours: 18:07
BioCryst Pharmaceuticals Cash and Short Term Investments (Quarterly): 388.99M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 388.99M |
| September 30, 2023 | 397.59M |
| June 30, 2023 | 410.67M |
| March 31, 2023 | 398.16M |
| December 31, 2022 | 424.31M |
| September 30, 2022 | 426.86M |
| June 30, 2022 | 417.48M |
| March 31, 2022 | 443.47M |
| December 31, 2021 | 507.60M |
| September 30, 2021 | 199.60M |
| June 30, 2021 | 218.43M |
| March 31, 2021 | 240.36M |
| December 31, 2020 | 300.37M |
| September 30, 2020 | 143.32M |
| June 30, 2020 | 189.40M |
| March 31, 2020 | 113.06M |
| December 31, 2019 | 136.23M |
| September 30, 2019 | 68.44M |
| June 30, 2019 | 92.15M |
| March 31, 2019 | 107.56M |
| December 31, 2018 | 104.47M |
| September 30, 2018 | 120.32M |
| June 30, 2018 | 80.74M |
| March 31, 2018 | 91.31M |
| December 31, 2017 | 114.40M |
| Date | Value |
|---|---|
| September 30, 2017 | 161.62M |
| June 30, 2017 | 80.67M |
| March 31, 2017 | 98.68M |
| December 31, 2016 | 54.65M |
| September 30, 2016 | 52.82M |
| June 30, 2016 | 35.74M |
| March 31, 2016 | 35.82M |
| December 31, 2015 | 51.56M |
| September 30, 2015 | 70.33M |
| June 30, 2015 | 94.36M |
| March 31, 2015 | 67.53M |
| December 31, 2014 | 72.77M |
| September 30, 2014 | 127.13M |
| June 30, 2014 | 132.11M |
| March 31, 2014 | 31.39M |
| December 31, 2013 | 38.06M |
| September 30, 2013 | 42.59M |
| June 30, 2013 | 29.12M |
| March 31, 2013 | 28.27M |
| December 31, 2012 | 35.60M |
| September 30, 2012 | 41.02M |
| June 30, 2012 | 34.88M |
| March 31, 2012 | 43.28M |
| December 31, 2011 | 41.72M |
| September 30, 2011 | 44.00M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
68.44M
Minimum
Sep 2019
507.60M
Maximum
Dec 2021
290.34M
Average
300.37M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 13.07M |
| Perspective Therapeutics Inc | 9.238M |
| Protalix BioTherapeutics Inc | 44.56M |
| Electromed Inc | 10.43M |
| Armata Pharmaceuticals Inc | 13.52M |